Literature DB >> 12068076

Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease.

Hui-Ming Gao1, Janwei Jiang, Belinda Wilson, Wanqin Zhang, Jau-Shyong Hong, Bin Liu.   

Abstract

The etiology of sporadic Parkinson's disease (PD) remains unknown. Increasing evidence has suggested a role for inflammation in the brain in the pathogenesis of PD. However, it has not been clearly demonstrated whether microglial activation, the most integral part of the brain inflammatory process, will result in a delayed and progressive degeneration of dopaminergic neurons in substantia nigra, a hallmark of PD. We report here that chronic infusion of an inflammagen lipopolysaccharide at 5 ng/h for 2 weeks into rat brain triggered a rapid activation of microglia that reached a plateau in 2 weeks, followed by a delayed and gradual loss of nigral dopaminergic neurons that began at between 4 and 6 weeks and reached 70% by 10 weeks. Further investigation of the underlying mechanism of action of microglia-mediated neurotoxicity using rat mesencephalic neuron-glia cultures demonstrated that low concentrations of lipopolysaccharide (0.1-10 ng/mL)-induced microglial activation and production of neurotoxic factors preceded the progressive and selective degeneration of dopaminergic neurons. Among the factors produced by activated microglia, the NADPH oxidase-mediated release of superoxide appeared to be a predominant effector of neurodegeneration, consistent with the notion that dopaminergic neurons are particularly vulnerable to oxidative insults. This is the first report that microglial activation induced by chronic exposure to inflammagen was capable of inducing a delayed and selective degeneration of nigral dopaminergic neurons and that microglia-originated free radicals play a pivotal role in dopaminergic neurotoxicity in this inflammation-mediated model of PD.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12068076     DOI: 10.1046/j.1471-4159.2002.00928.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  230 in total

1.  Cell biology. Anatomy of prostaglandin signals.

Authors:  Nephi Stella
Journal:  Science       Date:  2011-11-11       Impact factor: 47.728

2.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Du-Chu Wu; Peter Teismann; Kim Tieu; Miquel Vila; Vernice Jackson-Lewis; Harry Ischiropoulos; Serge Przedborski
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

Review 3.  NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.

Authors:  Hui-Ming Gao; Hui Zhou; Jau-Shyong Hong
Journal:  Trends Pharmacol Sci       Date:  2012-04-11       Impact factor: 14.819

Review 4.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

5.  Lymphocytes reduce nigrostriatal deficits in the 6-hydroxydopamine mouse model of Parkinson's disease.

Authors:  Chi Wang Ip; Sandra K Beck; Jens Volkmann
Journal:  J Neural Transm (Vienna)       Date:  2015-08-20       Impact factor: 3.575

6.  Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model.

Authors:  Rozina Noristani; Sandra Kuehn; Gesa Stute; Sabrina Reinehr; Mathias Stellbogen; H Burkhard Dick; Stephanie C Joachim
Journal:  J Mol Neurosci       Date:  2016-01-08       Impact factor: 3.444

7.  Head injury at early ages is associated with risk of Parkinson's disease.

Authors:  Kathryn M Taylor; Marie-Helene Saint-Hilaire; Lewis Sudarsky; David K Simon; Bonnie Hersh; David Sparrow; Howard Hu; Marc G Weisskopf
Journal:  Parkinsonism Relat Disord       Date:  2015-12-19       Impact factor: 4.891

8.  Induction of matrix metalloproteinase-3 (MMP-3) expression in the microglia by lipopolysaccharide (LPS) via upregulation of glycoprotein nonmetastatic melanoma B (GPNMB) expression.

Authors:  Fangyuan Shi; Shuangyan Duan; Jihong Cui; Xingrong Yan; Hongmin Li; Yingjuan Wang; Fulin Chen; Lihua Zhang; Jun Liu; Xin Xie
Journal:  J Mol Neurosci       Date:  2014-03-30       Impact factor: 3.444

9.  Lipopolysaccharide preconditioning induces protection against lipopolysaccharide-induced neurotoxicity in organotypic midbrain slice culture.

Authors:  Ye Ding; Liang Li
Journal:  Neurosci Bull       Date:  2008-08       Impact factor: 5.203

Review 10.  Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration.

Authors:  Juan A Orellana; Pablo J Sáez; Kenji F Shoji; Kurt A Schalper; Nicolás Palacios-Prado; Victoria Velarde; Christian Giaume; Michael V L Bennett; Juan C Sáez
Journal:  Antioxid Redox Signal       Date:  2009-02       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.